The Discounted Cash Flow (DCF) valuation of Amneal Pharmaceuticals Inc (AMRX) is 19.82 USD. With the latest stock price at 17.05 USD, the upside of Amneal Pharmaceuticals Inc based on DCF is 16.3%.
Based on the latest price of 17.05 USD and our DCF valuation, Amneal Pharmaceuticals Inc (AMRX) is a buy. buying Amneal stocks now will result in a potential gain of 16.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.7% | 6.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 9.91 - 62.98 | 19.82 |
| Upside | -41.9% - 269.4% | 16.3% |